These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1199584)

  • 1. [Further study of the sensitivity to erythromycin of strains of the causative agent of tularemia from different geographical sites].
    Kudelina RI; Olsuf'ev NG
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):146-7. PubMed ID: 1199584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivity of various races of the tularemia microbe to erythromycin, oleandomycin and polymyxin].
    Brikman DI; Zakhlebnaia OD
    Antibiotiki; 1976 Feb; 21(2):134-6. PubMed ID: 179462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change in the properties of the causative agent of tularemia due to erythromycin].
    Kudelina RI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Dec; 50(12):98-101. PubMed ID: 4785841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity of the causative agent of tularemia to antibiotics].
    Kudelina RI
    Antibiotiki; 1978 Aug; 23(8):710-4. PubMed ID: 686695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Geographical race typing of the causative agent of tularemia using antibiotics].
    Chimirov OB; Aĭkimbaev MA
    Antibiotiki; 1978 Sep; 23(9):816-9. PubMed ID: 151527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity to macrolide antibiotics and lincomycin in Francisella tularensis holarctica.
    Kudelina RI; Olsufiev NG
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(1):84-91. PubMed ID: 7190590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity to the differential dose of erythromycin and oleandomycin of various holarctic strains of tularemia microbe isolated in the Kazakh SSR].
    Chimirov OB
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):119-21. PubMed ID: 150182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of F. tularensis susceptibility to erythromycin in vitro (author's transl)].
    Výrosteková V; Gurycová D
    Cesk Epidemiol Mikrobiol Imunol; 1978 Jun; 27(3):161-6. PubMed ID: 151594
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro antibiotic susceptibility of Francisella tularensis isolates from Japan.
    Hotta A; Fujita O; Uda A; Sharma N; Tanabayashi K; Yamamoto Y; Yamada A; Morikawa S
    Jpn J Infect Dis; 2013; 66(6):534-6. PubMed ID: 24270145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative characteristics of biological properties of Francisella tularensis strains isolated in the USSR].
    Pavlovich NV; Mishan'kin BN; Tynkevich NK; Ryzhko IV; Romanova LV; Danilevskaia GI
    Antibiot Khimioter; 1991 Oct; 36(10):23-5. PubMed ID: 1805689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonality of erythromycin resistance in Francisella tularensis.
    Karlsson E; Golovliov I; Lärkeryd A; Granberg M; Larsson E; Öhrman C; Niemcewicz M; Birdsell D; Wagner DM; Forsman M; Johansson A
    J Antimicrob Chemother; 2016 Oct; 71(10):2815-23. PubMed ID: 27334667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First isolation of Francisella tularensis subsp. tularensis in Europe.
    Gurycová D
    Eur J Epidemiol; 1998 Dec; 14(8):797-802. PubMed ID: 9928875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
    Kiliç S; Celebi B; Acar B; Ataş M
    Scand J Infect Dis; 2013 May; 45(5):337-41. PubMed ID: 23249114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pleiotropic nature of mutation of resistance to 2,3,5-triphenyl- tetrazolium chloride of Francisella tularensis].
    Pavlovich NV; Danilevskaia GI; Khodova VA; Ryzhko IV; Mishan'kin BN
    Antibiot Khimioter; 1992 Apr; 37(4):28-31. PubMed ID: 1417312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of tularemia, including pulmonary tularemia, with gentamicin.
    Mason WL; Eigelsbach HT; Little SF; Bates JH
    Am Rev Respir Dis; 1980 Jan; 121(1):39-45. PubMed ID: 7352712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the effectiveness of amikacin and streptomycin in experimental tularemia].
    Tynkevich NK; Pavlovich NV; Ryzhko IV
    Antibiot Khimioter; 1990 Aug; 35(8):35-7. PubMed ID: 2264751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Diversity and Spatial Segregation of
    Appelt S; Köppen K; Radonić A; Drechsel O; Jacob D; Grunow R; Heuner K
    Front Cell Infect Microbiol; 2019; 9():376. PubMed ID: 31781515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitivity spectrum of Francisella tularensis to antibiotics and synthetic antibacterial drugs].
    Vasi'lev NT; Oborin VA; Vasi'lev PG; Glushkova OV; Kravets ID; Levchuk BA
    Antibiot Khimioter; 1989 Sep; 34(9):662-5. PubMed ID: 2610533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.
    Johansson A; Urich SK; Chu MC; Sjöstedt A; Tärnvik A
    Scand J Infect Dis; 2002; 34(5):327-30. PubMed ID: 12069013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    Caspar Y; Hennebique A; Maurin M
    J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.